Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

89
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
89
Biostatistics: Overview01:20

Biostatistics: Overview

379
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
379
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

4.3K
The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
4.3K
Study Design in Statistics01:15

Study Design in Statistics

8.6K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
8.6K
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

546
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
546
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

396
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
396

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative Systems Pharmacology Modeling Amid the Rise of Agentic AI.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Follow-Up Bias in Tumor Dynamic Modeling: A Comparison of Classical and Neural-ODE Approaches.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development.

Clinical pharmacology and therapeutics·2025
Same author

Building Hybrid Pharmacometric-Machine Learning Models in Oncology Drug Development: Current State and Recommendations.

CPT: pharmacometrics & systems pharmacology·2025
Same author

FDA-AACR Strategies for Optimizing Dosages for Oncology Drug Products: Selecting Optimized Dosages for Registrational Trials.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Safety, Pharmacokinetics, and Immunogenicity of Astegolimab, an Anti-ST2 Monoclonal Antibody, in Randomized, Phase I Clinical Studies.

Clinical and translational science·2025

Related Experiment Video

Updated: Sep 17, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

Shap-Cov: An Explainable Machine Learning Based Workflow for Rapid Covariate Identification in Population Modeling.

Logan Brooks1, Rashed Harun2, Jin Y Jin1

  • 1Clinical Pharmacology, Genentech, Inc., South San Francisco, California, USA.

CPT: Pharmacometrics & Systems Pharmacology
|July 2, 2025
PubMed
Summary

This study introduces a novel machine learning approach for identifying important factors (covariates) in population pharmacokinetic/pharmacodynamic (popPK/PD) models. The method enhances model development by reducing bias and improving efficiency in complex scenarios.

Keywords:
artificial intelligencecovariate‐analysismachine learningpopulation PK/PD

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.8K

Related Experiment Videos

Last Updated: Sep 17, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.8K

Area of Science:

  • Pharmacometrics
  • Computational Biology
  • Statistical Modeling

Background:

  • Covariate identification is crucial for population pharmacokinetic/pharmacodynamic (popPK/PD) model development.
  • Traditional methods are often biased, time-consuming, and struggle with complex models or numerous covariates.
  • Machine learning (ML) offers a promising alternative for covariate screening.

Purpose of the Study:

  • To develop and package an improved ML-driven methodology for covariate identification in popPK/PD modeling.
  • To integrate explainable AI (XAI) and uncertainty quantification for robust covariate assessment.
  • To provide a statistically rigorous framework for evaluating covariate significance.

Main Methods:

  • Integration of Shapley Additive Explanations (SHAP) for explainable ML-based covariate screening.
  • Inclusion of covariate uncertainty quantification to assess the reliability of identified relationships.
  • Development of a formal statistical framework to establish the significance of covariate effects.
  • Packaging the methodology into a user-friendly function set (shap-cov).

Main Results:

  • The proposed methodology effectively identifies significant covariates in popPK/PD models.
  • Explainable AI (SHAP) provides insights into the contribution of each covariate.
  • Uncertainty quantification helps in assessing the robustness of covariate findings.
  • The shap-cov package streamlines the covariate identification process.

Conclusions:

  • The novel ML-based approach, incorporating SHAP and uncertainty quantification, offers a more efficient, less biased, and statistically sound method for covariate identification in popPK/PD modeling.
  • The shap-cov package provides a practical tool for researchers to enhance their popPK/PD model development.
  • This work advances the application of AI in pharmacometrics for more reliable drug development and personalized medicine.